International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, #855 Xingye Avenue, Guangzhou, 511400, China.
International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, #855 Xingye Avenue, Guangzhou, 511400, China.
Eur J Med Chem. 2024 Apr 5;269:116339. doi: 10.1016/j.ejmech.2024.116339. Epub 2024 Mar 22.
The low permeability of the outer membrane of Gram-negative bacteria is a serious obstacle to the development of new antibiotics against them. Conjugation of antibiotic with siderophore based on the "Trojan horse strategy" is a promising strategy to overcome the outer membrane obstacle. In this study, series of antibacterial agents were designed and synthesized by conjugating the 3-hydroxypyridin-4(1H)-one based siderophores with cajaninstilbene acid (CSA) derivative 4 which shows good activity against Gram-positive bacteria by targeting their cell membranes but is ineffective against Gram-negative bacteria. Compared to the inactive parent compound 4, the conjugates 45c or 45d exhibits significant improvement in activity against Gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae and especially P. aeruginosa (minimum inhibitory concentrations, MICs = 7.8-31.25 μM). The antibacterial activity of the conjugates is attributed to the CSA derivative moiety, and the action mechanism is by disruption of bacterial cell membranes. Further studies on the uptake mechanisms showed that the bacterial siderophore-dependent iron transport system was involved in the uptake of the conjugates. In addition, the conjugates 45c and 45d showed a lower cytotoxic effects in vivo and in vitro and a positive therapeutic effect in the treatment of C. elegans infected by P. aeruginosa. Overall, our work describes a new class and a promising 3-hydroxypyridin-4(1H)-one-CSA derivative conjugates for further development as antibacterial agents against Gram-negative bacteria.
革兰氏阴性菌外膜的低通透性是开发针对它们的新型抗生素的严重障碍。基于“木马策略”将抗生素与铁载体偶联是克服外膜障碍的一种很有前途的策略。在这项研究中,通过将基于 3-羟基吡啶-4(1H)-酮的铁载体与具有良好抗革兰氏阳性菌活性的 cajaninstilbene 酸(CSA)衍生物 4 偶联,设计并合成了一系列抗菌剂,该衍生物通过靶向其细胞膜起作用,但对革兰氏阴性菌无效。与无活性的母体化合物 4 相比,偶联物 45c 或 45d 对革兰氏阴性菌(包括大肠杆菌、肺炎克雷伯菌,尤其是铜绿假单胞菌)的活性有显著提高(最低抑菌浓度,MICs=7.8-31.25 μM)。偶联物的抗菌活性归因于 CSA 衍生物部分,作用机制是破坏细菌细胞膜。进一步的摄取机制研究表明,细菌铁载体依赖性铁转运系统参与了偶联物的摄取。此外,偶联物 45c 和 45d 在体内和体外的细胞毒性作用较低,并且在治疗铜绿假单胞菌感染秀丽隐杆线虫方面具有积极的治疗效果。总的来说,我们的工作描述了一类新的 3-羟基吡啶-4(1H)-酮-CSA 衍生物偶联物,它们具有作为针对革兰氏阴性菌的抗菌剂进一步开发的潜力。